Ftse Mib
38.592,81
-0,48%
DAX
23.008,94
-1,87%
S&P 500
5.770,20
0,55%
NASDAQ
18.196,22
0,70%
Bitcoin
83.474,88
-3,11%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Taysha Gene Therapies Inc (TSHA) Taysha Gene Therapies Inc (TSHA) Notizie

Taysha Gene Therapies Inc

TSHA
1,75
0,06 (3,55%)
08 Mar 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
07/3/202514:00GLOBETaysha Gene Therapies Announces Inducement Grant Under..
26/2/202514:44EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
26/2/202514:06EDGAR2Form 8-K - Current report
26/2/202514:00GLOBETaysha Gene Therapies Reports Full-Year 2024 Financial..
19/2/202514:00GLOBETaysha Gene Therapies to Release Full-Year 2024 Financial..
07/2/202514:00GLOBETaysha Gene Therapies Announces Inducement Grant Under..
06/2/202500:05EDGAR2Form SCHEDULE 13G - Statement of Beneficial Ownership by..
07/1/202522:34EDGAR2Form S-8 - Securities to be offered to employees in employee..
03/1/202514:00GLOBETaysha Gene Therapies Announces Inducement Grant Under..
13/12/202422:05EDGAR2Form S-3 - Registration statement under Securities Act of..
06/12/202414:00GLOBETaysha Gene Therapies Announces Inducement Grant Under..
13/11/202422:38EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202422:01GLOBETaysha Gene Therapies Reports Third Quarter 2024 Financial..
08/11/202420:17EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
06/11/202414:00GLOBETaysha Gene Therapies to Release Third Quarter 2024..
01/11/202421:30GLOBETaysha Gene Therapies Announces Inducement Grant Under..
22/10/202414:00GLOBETaysha Gene Therapies to Present Biodistribution Data from..
04/10/202414:01GLOBETaysha Gene Therapies Announces Inducement Grant Under..
26/9/202414:00GLOBETaysha Gene Therapies Announces Oral Presentation on..
06/9/202414:00GLOBETaysha Gene Therapies Announces Inducement Grant Under..
12/8/202414:32EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/8/202414:05EDGAR2Form 8-K - Current report
12/8/202414:01GLOBETaysha Gene Therapies Reports Second Quarter 2024 Financial..
05/8/202414:00GLOBETaysha Gene Therapies to Release Second Quarter 2024..
02/8/202414:00GLOBETaysha Gene Therapies Announces Inducement Grant Under..
05/7/202423:51EDGAR2Form 144 - Report of proposed sale of securities
05/7/202423:50EDGAR2Form 144 - Report of proposed sale of securities
05/7/202423:49EDGAR2Form 144 - Report of proposed sale of securities
05/7/202414:00GLOBETaysha Gene Therapies Announces Inducement Grant Under..
26/6/202415:14GLOBETaysha Gene Therapies Announces Pricing of Public Offering..
26/6/202400:34GLOBETaysha Gene Therapies Announces Proposed Public Offering of..
18/6/202413:45EDGAR2Form 8-K - Current report
18/6/202413:30GLOBETaysha Gene Therapies Announces Positive Clinical Data..
07/6/202414:00GLOBETaysha Gene Therapies Announces Inducement Grant Under..
31/5/202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/5/202422:02EDGAR2Form 8-K - Current report
14/5/202422:18EDGAR2Form 8-K - Current report
14/5/202422:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/5/202422:01GLOBETaysha Gene Therapies Reports First Quarter 2024 Financial..
07/5/202422:05GLOBETaysha Gene Therapies to Release First Quarter 2024..
03/5/202422:05GLOBETaysha Gene Therapies Announces Inducement Grant Under..
02/5/202414:00GLOBETaysha Gene Therapies Announces Regenerative Medicine..
05/4/202414:00GLOBETaysha Gene Therapies Announces Inducement Grant Under..
20/3/202418:30APSAnother Biotech Steals The Show Following Major Clinical..
19/3/202421:01GLOBETaysha Gene Therapies Reports Full Year 2023 Financial..
19/3/202412:27IHMARKETNEWSUS Index Futures Decline Ahead of Federal Reserve Meeting,..
14/3/202421:26GLOBETaysha Gene Therapies to Release Full-Year 2023 Financial..
Apertura: 1,68 Min: 1,66 Max: 1,765
Chiusura: 1,69

La tua Cronologia

NASDAQ
TSHA
Taysha Gene Therapies
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci